PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAgile Therapeutics
Agile Therapeutics(AGRX)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
TwirlaEthinyl estradiol, Levonorgestrel2020-02-142023-2039
Prostatic neoplasms
,
Breast neoplasms
,
Menorrhagia
,
Uterine hemorrhage
,
Contraception
,
Primary ovarian insufficiency
,
Amenorrhea
,
Hot flashes
,
Hypogonadism
,
Premature menopause
,
Acne vulgaris
,
Endometriosis
,
Endometrial hyperplasia
,
Menstruation disturbances
,
Female infertility
,
Folic acid deficiency
,
Megaloblastic anemia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ethinyl estradiol
healthy volunteers/patients
,
microbial drug resistance
,
bacterial conjunctivitis
,
conjunctivitis
,
infections
,
communicable diseases
,
eye infections
Levonorgestrel
vision disorders
,
ovulation inhibition
,
healthy volunteers/patients
,
contraception
Trinessa
pneumonia
,
community-acquired infections
,
bacterial pneumonia
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use